Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.76
+0.32 (3.07%)
At close: Feb 26, 2026, 4:00 PM EST
10.76
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:10 PM EST
Haleon Revenue
In the year 2025, Haleon had annual revenue of 11.03B GBP, down -1.81%. Haleon had revenue of 2.78B in the quarter ending December 31, 2025, a decrease of -0.18%.
Revenue (ttm)
11.03B GBP
Revenue Growth
-1.87%
P/S Ratio
3.20
Revenue / Employee
449,086 GBP
Employees
24,561
Market Cap
47.44B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.03B | -203.00M | -1.81% |
| Dec 31, 2024 | 11.23B | -69.00M | -0.61% |
| Dec 31, 2023 | 11.30B | 444.00M | 4.09% |
| Dec 31, 2022 | 10.86B | 1.31B | 13.76% |
| Dec 31, 2021 | 9.55B | -347.00M | -3.51% |
| Dec 31, 2020 | 9.89B | 1.41B | 16.65% |
| Dec 31, 2019 | 8.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 28.48B |
| Teva Pharmaceutical Industries | 17.26B |
| Viatris | 14.12B |
| Zoetis | 9.47B |
| Elanco Animal Health | 4.59B |
| Dr. Reddy's Laboratories | 3.85B |
| United Therapeutics | 3.13B |
| Neurocrine Biosciences | 2.86B |
HLN News
- 1 day ago - Haleon plc (HLN) Q4 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 1 day ago - Haleon plc (HLN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Haleon PLC (HLN) Shares Down 7.08% on Feb 25 - GuruFocus
- 1 day ago - Haleon plc 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Haleon PLC (HLN) Q4 2025 Earnings Call Highlights: Strategic Changes and Market Challenges - GuruFocus
- 1 day ago - Q4 2025 Haleon PLC Earnings Call Transcript - GuruFocus
- 1 day ago - Haleon CEO: Optimistic about our growth within oral hygiene - CNBC
- 1 day ago - Haleon FY25 Profit Climbs, Revenues Down; Sees Growth In FY26, Mid-term; Plans GBP 500 Mln Buyback - Nasdaq